|  Nederlands |  English |
 
 
04/04/2002: Janssen Pharmaceutica NV receives Randstad Award for Most Engaging Employer in Belgium

The award is the result of a survey run by the research bureau ICMA, assigned by Randstad. During the survey 6.000 respondents from all over Belgium received a list with the names of 107 companies and were asked whether they knew the companies, if they would like to be employed by them and why?

 

Janssen Pharmaceutica came out top of the list in five out of the eight investigated features. Because of its high score on financial health, long term security and good perspectives, Janssen Pharmaceutica stood above companies like Pharmacia & Upjohn, IBM, Coco Cola, General Electric, Siemens, Monsanto and many others in the survey.

During a short ceremony in Brussels on March 4, 2002, Stef Witteveen, CEO of Randstad handed the award to Janssen Pharmaceutica CEO, Ajit Shetty in attendance of the press. In his acceptance speech Ajit Shetty stressed the important role of the 4000 Janssen employees in Belgium in earning this award.

 
Press Releases 2002
04/12/2002 Laboratory Technician Day on December 4, 2002 for the Kempen Catholic Technical College of Geel: an opportunity to become acquainted with Janssen Pharmaceutica in Beerse and… perhaps even the key to your future!
11/12/2002 Janssen Pharmaceutica invests another 50 million euros
08/10/2002 Scientists elect Johnson & Johnson as third most attractive employer in the world
20/09/2002 Janssen Pharmaceutica Goes for Public Transportation
10/09/2002 Durogesic reaches a milestone
01/09/2002 Risperdal Consta, a new generation of atypical antipsychotics
04/07/2002 2001 - A very successful year for Janssen Pharmaceutica
03/07/2002 Prime Minister Guy Verhofstadt lays the first stone of the new Discovery Research Center in Beerse
22/05/2002 "Beerse 2" is biggest computer- and telecomcenter for J&J-group in Europe
05/05/2002 Open house at Janssen Pharmaceutica in Geel a success!
18/04/2002 Data suggest Reminyl effectively treats dementia in patients with cerebrovascular disease
15/04/2002 Investing in research: patients are Worth the Risk
12/04/2002 J&J in top 50 Business week
04/04/2002 Janssen Pharmaceutica NV most engaging employer in Belgium
 

 

 
© Janssen Pharmaceutica N.V., 1997-2010.

This site is published by Janssen Pharmaceutica NV and is intended for visitors from Europe. Use of the site constitutes your consent to application of European laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.